MENU

Asya Nina Varshavsky-Yanovsky, MD, PhD

Asya Varshavsky-Yanovsky, MD, PhD

Clinical Locations

Primary Location

Fox Chase–Temple University Hospital Bone Marrow Transplant Program
Jeanes Hospital
Patient Care Center, Fifth Floor
7600 Central Avenue
Philadelphia, PA 19111

About

Assistant Professor, Department of Hematology/Oncology

Fox Chase-Temple University Hospital Bone Marrow Transplant Program

Specialties

Treatment Focus

Stem cell transplant, cellular therapies

Language(s) Other than English

Hebrew;  Russian

Treatment Philosophy

After completing my fellowship at Fox Chase, I’m delighted to continue my career here, joining the collaborative team of outstanding clinicians and researchers, dedicated to providing best care to our patients. My philosophy of care is to treat every patient like family. This means educating them fully about their treatment options and helping them make the right decision for the best possible outcome. A diagnosis of cancer can be challenging to deal with, but with a caring, experienced team behind a patient, the journey can feel less stressful.

Education and Training

Educational Background

  • Fellow, Fox Chase/ Temple Hematology/ Oncology, Philadelphia, PA, 2016-19
  • Jacobi/Albert Einstein College of Medicine, Intern and Resident in Internal Medicine       Bronx, NY, 2013–16
  • MD, Technion, Haifa, Israel, 2012
  • PhD, Medicine, Technion, Haifa, Israel , 2009
  • BSc, Medicine, Technion, Haifa, Israel, 2004

Certifications

  • ABIM Internal Medicine

Honors & Awards

  • The Hershel Rich Innovation Award for outstanding research projects, 2011
  • Top 5% Medicine graduates in Israel, 2011
  • Zieff Fine Neeman scholarship award for distinguished students, 2007
Publications

Selected Publications

Pooja Ghatalia, Chad H. Smith, Arthur Winer, Jiangtao Gou , Lesli A. Kiedrowski, Michael Slifker, Patricia D. Saltzberg, Nicole Bubes, Fern M. Anari, Vineela Kasireddy, Asya Varshavsky , Yang Liu, Eric A. Ross,  Wafik S. El-Deiry  Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in Oncology 2019.

Shastri, A., Schinke, C., Varshavsky Yanovsky, A., Bhagat, T. D., Giricz, O.,Barreyro, L., Boultwood, J., Pellagati, A., Yu, Y., Brown, J. R., Frank, D. A.,Das, B., Kambhampati, S., Will, B., Steidl, U., & Verma, A Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine. Blood 2014, 124(21).

Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G (2011) Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood. 2011 Aug 10.

Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufeld G (2008) Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin like pro-protein convertases. Cancer research, 68, 6922-6931.

Kigel B, Varshavsky A, Kessler O, Neufeld, G (2008) Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PlosOne, 3, e3287.

Gutmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G (2007) Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem., 282, 26294-26305.

Neufeld G, Lange T, Varshavsky A, Kessler O (2006) Semaphorin signaling in vascular and tumor biology. Adv. Exp. Med. Biol. 600, 118-131.

Connect with Fox Chase